Literature DB >> 31520226

Precision medicine in rheumatoid arthritis: are we there yet?

Karen Salomon-Escoto1.   

Abstract

Entities:  

Year:  2019        PMID： 31520226     DOI： 10.1007/s10067-019-04766-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  15 in total

1.  Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.

Authors:  Jeffrey R Curtis; Lang Chen; Maria I Danila; Kenneth G Saag; Kathy L Parham; John J Cush
Journal:  J Rheumatol       Date:  2017-11-15       Impact factor: 4.666

Review 2.  Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.

Authors:  Lilian H D van Tuyl; Steven C Vlad; David T Felson; George Wells; Maarten Boers
Journal:  Arthritis Rheum       Date:  2009-05-15

3.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

Authors:  Catriona Grigor; Hilary Capell; Anne Stirling; Alex D McMahon; Peter Lock; Ramsay Vallance; Wilma Kincaid; Duncan Porter
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

4.  RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.

Authors:  Theodore Pincus; Christopher J Swearingen; Martin Bergman; Yusuf Yazici
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

5.  Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Authors:  D Aletaha; R Landewe; T Karonitsch; J Bathon; M Boers; C Bombardier; S Bombardieri; H Choi; B Combe; M Dougados; P Emery; J Gomez-Reino; E Keystone; G Koch; T K Kvien; E Martin-Mola; M Matucci-Cerinic; K Michaud; J O'Dell; H Paulus; T Pincus; P Richards; L Simon; J Siegel; J S Smolen; T Sokka; V Strand; P Tugwell; D van der Heijde; P van Riel; S Vlad; R van Vollenhoven; M Ward; M Weinblatt; G Wells; B White; F Wolfe; B Zhang; A Zink; D Felson
Journal:  Ann Rheum Dis       Date:  2008-10       Impact factor: 19.103

6.  Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).

Authors:  S M M Verstappen; J W G Jacobs; M J van der Veen; A H M Heurkens; Y Schenk; E J ter Borg; A A M Blaauw; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-05-22       Impact factor: 19.103

7.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Arthritis Rheum       Date:  2011-03

8.  The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.

Authors:  Leslie R Harrold; George W Reed; J Timothy Harrington; Christine J Barr; Katherine C Saunders; Allan Gibofsky; Jeffrey D Greenberg; Ani John; Jenny Devenport; Joel M Kremer
Journal:  BMC Musculoskelet Disord       Date:  2014-11-21       Impact factor: 2.362

Review 9.  Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.

Authors:  Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2015-05-12       Impact factor: 19.103

10.  A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.

Authors:  Karen Hambardzumyan; Saedis Saevarsdottir; Kristina Forslind; Ingemar F Petersson; Johan K Wallman; Sofia Ernestam; Rebecca J Bolce; Ronald F van Vollenhoven
Journal:  Arthritis Rheumatol       Date:  2017-03-31       Impact factor: 10.995
View more
  1 in total

1.  Making space for patients' preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis.

Authors:  Karin Schölin Bywall; Jennifer Viberg Johansson; Inger Erlandsson; Marie Heidenvall; Marta Lason; Bente Appel Esbensen
Journal:  BMJ Open       Date:  2022-06-01       Impact factor: 3.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.